| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $514.8M | +9.6% |
| Cost of Revenue | $184.7M | +17.7% |
| R&D Expense | $193.7M | +22.3% |
| SG&A Expense | $120.6M | +57.2% |
| Operating Income | -$221.9M | -137.9% |
| Interest Expense | $5.5M | -85.3% |
| Income Tax | $1.7M | +171.8% |
| Net Income | -$225.7M | -80.6% |
| EPS (Basic) | -$3.03 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $391.8M | -24.9% |
| Accounts Receivable | $86.5M | -7.7% |
| Current Assets | $533.5M | -16.2% |
| Total Assets | $1.09B | -8.2% |
| Current Liabilities | $253.8M | +13.6% |
| Long-term Debt | $737.4M | +28.4% |
| Total Liabilities | $1.02B | +21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.1M | -2012.6% |
| Capital Expenditures | $48.5M | +6.1% |
| Investing Cash Flow | -$56.9M | +59.5% |
| Financing Cash Flow | $1.6M | -86.3% |
| Free Cash Flow | -$110.6M | -160.5% |
| -68.3% |
| EPS (Diluted) | -$3.03 | -68.3% |
| Stockholders' Equity |
| $68.1M |
| -80.5% |